Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
PEPetVivo Holdings, Inc. logo

PetVivo Holdings, Inc. (PETV)

Other OTC · Currency in USD
$0.70 ▲ +0.01 (+1.89%)
At close: Oct 23, 4:00 PM ET. Market closed.

Summary

Previous Close
$0.69
Open
$0.69
Day's Range
$0.69 – $0.70
52 Week Range
$0.59 – $1.69
Volume
5,473
Avg. Volume
12,396
Market Cap
$26.57M
Beta (5Y Monthly)
1.34
PE Ratio (TTM)
--
EPS (TTM)
-$0.26
Earnings Date
Nov 12, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
--

Profile: PetVivo Holdings, Inc.

Sector
Healthcare
Industry
Medical - Devices
Full-time employees
22
CEO
John Lai

PetVivo Holdings, Inc. operates as a biomedical technology firm, specializing in the invention, commercialization, and licensing of advanced medical devices and biomaterials intended to treat a variety of ailments and diseases affecting animals. Its flagship product is Spryng, an intra-articular injection administered by veterinarians to effectively alleviate lameness and joint conditions, such as osteoarthritis, in canines and equines. The company's development pipeline further includes seventeen therapeutic devices poised for both veterinary and human clinical applications.

Earnings

Next report: Thu, Nov 12, 2026
EPS estimate -$0.08 · Revenue est. $5.00K
DateEst.Actual
Aug 14, 2026-$0.08-$0.05Beat
Jun 29, 2026–-$0.11
Feb 17, 2026–-$0.07
Nov 14, 2025–-$0.11
Aug 14, 2025–-$0.09
Jun 30, 2025–-$0.12

Get free alerts on PETV and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.